ILANA HURRLE: Open Payments
NPI 1437118866 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 42 payments from 17 companies in 2025. Trend: 2023 $648 · 2024 $829 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $223 |
| Alexion Pharmaceuticals, Inc. | 2 | $56 |
| Lilly USA, LLC | 3 | $52 |
| Novo Nordisk Inc | 3 | $52 |
| Astellas Pharma US Inc | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $32 |
| Abbott Laboratories | 2 | $32 |
| Amgen Inc. | 2 | $32 |
| Exact Sciences Corporation | 2 | $29 |
| Fisher & Paykel Healthcare Inc | 1 | $28 |
Products named: VRAYLAR, UBRELVY, STRENSIQ, MOUNJARO, QULIPTA, Veozah, Qelbree, FREESTYLE LIBRE 3.
Industry payments across IN — which companies pay providers there.
